ArticleJournal of laboratory physicians2023
Ceftriaxone Resistant Salmonella enterica Serovar Kentucky as a Cause of Bacteremia and Gastroenteritis: A Case Report.
Article in Journal of laboratory physicians, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 6 citations in OpenAlex.
- Whole genome-sequence-based molecular characterisation of Salmonella Kentucky co-resistant to fluoroquinolones and cephalosporins isolated from children during 2017 to 2024: emergence of blaBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026Article
- Myocarditis associated withFrontiers in medicine · 2025Article
- The First-Ever Encounter withInfectious disease reports · 2024Article
- Ceftriaxone-resistantFrontiers in public health · 2024Article
- One Health Approach: Invasive California Kingsnake (Animals : an open access journal from MDPI · 2023Article
- Mycotic Thoracic Aortic Aneurysm Due toJournal of global infectious diseasesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Salmonella enterica serovar Kentucky is an emerging human pathogen in developed countries and also a concern for public health in developing countries. Although genus Salmonella is usually susceptible to many antimicrobial agents, a recent increase in resistance has become a cause for concern. A case of ceftriaxone resistant Salmonella enterica serovar Kentucky causing bacteremia and acute gastroenteritis is reported in this paper. The Salmonella Kentucky isolate in this case was resistant to most classes of antibiotics. This is the first case report of Salmonella enterica serovar Kentucky resistant to ceftriaxone. Multidrug resistant patterns of Salmonella Kentucky are observed globally. Awareness of various nontyphoid Salmonella causing human infections is of utmost importance, because delayed identification, serotyping, and susceptibility testing may delay the administration of antibiotics leading to worsening outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.